| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/19/2004 | US20040033607 Comprises nucleotide sequences coding vernalization independence polypeptides (VIP) for contolling the time of flowering in agriculure important crop plants such as tomatoes, corn and lettuce |
| 02/19/2004 | US20040033606 Comprises nucleotide sequences coding mitochondrial enzymatic polypeptide for improving fatty acid biosynthesis, glycerolipid storage, seed size and weight, flowering and generation time of plants; antisense therapy |
| 02/19/2004 | US20040033603 Biotinylation of proteins |
| 02/19/2004 | US20040033602 Using small interfering RNA (siRNA) sequences and polypeptides containing enzymatic domains to control gene expression in cell systems; antisense agents |
| 02/19/2004 | US20040033594 Comprises RNA viral sequences for use in development of diagnostics and genetic vaccines against viral infection |
| 02/19/2004 | US20040033582 Human single nucleotide polymorphisms |
| 02/19/2004 | US20040033566 Genetically engineered serine protease for diagnosis and treatment of blood disorders |
| 02/19/2004 | US20040033564 Method for increasing solubility of target protein using RNA-binding protein as fusion partner |
| 02/19/2004 | US20040033561 Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033514 Detection of disease related genes |
| 02/19/2004 | US20040033512 Comprises carbohydrate-assoaiated proteins (CARBAP) for diagnosing, treating and/or preventing cell proliferative, autoimmune/inflammatory, reproductive and nervous system disorders |
| 02/19/2004 | US20040033504 Novel compounds |
| 02/19/2004 | US20040033500 Comprises nucleotide sequences coding N-methyl-D-aspartate type 3B (NR3B) polypeptides for diagnosing and treating nervous system disorders; antisense agents |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033236 Recombinant constructs of borrelia burgdorferi |
| 02/19/2004 | DE10236034A1 New labeling material, useful in marking products for protection against counterfeiting, comprises nucleic acid encapsulated in soluble or meltable packaging |
| 02/19/2004 | CA2534874A1 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | CA2495563A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2494930A1 Modified forms of interfering rna molecules |
| 02/19/2004 | CA2493716A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/18/2004 | EP1389637A1 Novel forms of interfering RNA molecules |
| 02/18/2004 | EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/18/2004 | EP1070079B1 Method for the production of pentopyranosyl nucleosides |
| 02/18/2004 | EP0720482B1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/18/2004 | CN1476485A Reagent box used for detecting non pathogenic or pathogenic A type influenze virus H5 subtype virus |
| 02/18/2004 | CN1475570A Cutin forming cell growth factor-2 |
| 02/18/2004 | CN1475568A New type human death resist protein, its coded sequence and use |
| 02/18/2004 | CN1475503A New type human bone marrow substrate cell source growth inhibiting factor, its coded sequence and use |
| 02/18/2004 | CN1475502A New withered induced protein, its coded sequence and use |
| 02/18/2004 | CN1475501A New type human bone marrow substrate cell source 1 type phosphoric acid enzyme inhibition factor, its coded sequence and use |
| 02/18/2004 | CN1475500A New type human marrow differentiation tagged object its coded sequence and use |
| 02/18/2004 | CN1475499A New type human cell signal related protein, its code sequence and use |
| 02/18/2004 | CN1475493A Method of separating whole length, complete messenger RNA from total RNA |
| 02/18/2004 | CN1138784C Action of antisense nucleic acid pointing at urokinase type plasminogen activating agent gene for inhibiting cancer |
| 02/17/2004 | WO2004076645A3 Compositions and methods for cytomegalovirus treatment |
| 02/17/2004 | US6693187 Enhancing nuclease resistance |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6692965 Exposing to molecular beacon comprised of nucleotides complementary to rna of interest; isolating cells that fluoresce upon hybridization |
| 02/17/2004 | US6692959 Hybrid nucleic acids; prevent, controlling gene expression; antiinflammatory agents |
| 02/17/2004 | US6692949 Having amino acid sequence comprising id 2 |
| 02/17/2004 | US6692948 Isolated human kinase proteins |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692924 Methods of using cytokine receptor zalpha11 to detect its ligands |
| 02/17/2004 | US6692912 Polymerizable complex containing a covalently attached nucleic acid molecule which, under appropriate conditions, is capable of copolymerization with a second polymerizable ethylene-containing monomer unit on solid support |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/16/2004 | CA2437478A1 Brassica pdhk gene |
| 02/12/2004 | WO2004013609A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004013606A2 Species specific dna detection |
| 02/12/2004 | WO2004013356A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 02/12/2004 | WO2004013327A1 Method for the expression of unknown environmental dna into adapted host cells |
| 02/12/2004 | WO2004013291A2 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli |
| 02/12/2004 | WO2004013280A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING |
| 02/12/2004 | WO2004013155A2 Stabilisation of nucleic acids |
| 02/12/2004 | WO2004013154A1 Method for preparing oligonucleotides |
| 02/12/2004 | WO2004013070A2 Multi-step synthesis of templated molecules |
| 02/12/2004 | WO2004012745A1 Antisense modulation of perilipin expression |
| 02/12/2004 | WO2004012588A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2003104398A3 Allelic variation in human gene expression |
| 02/12/2004 | WO2003095608A3 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 02/12/2004 | WO2003083053A3 Constructing very long dna sequences from synthetic dna molecules |
| 02/12/2004 | WO2003082901A3 Template-driven processes for synthesizing polymers and components related to such processes |
| 02/12/2004 | WO2003076566A3 Enzymatic ligation-based identification of nucleotide sequences |
| 02/12/2004 | WO2003070968A3 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003039404A3 Methods for treating ocular neovascular diseases |
| 02/12/2004 | WO2003039346A3 Diagnostics and therapeutics for ocular abnormalities |
| 02/12/2004 | WO2003018776A3 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS |
| 02/12/2004 | WO2002062952A3 Non-cytotoxic pap mutants |
| 02/12/2004 | US20040031072 Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| 02/12/2004 | US20040030118 Methods for regulating hematopoiesis using CpG-oligonucleotides |
| 02/12/2004 | US20040030117 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040030111 Used in directing the misfolding of functional RNA molecules that are characterized by secondary and/or tertiary folding to achieve an active conformation, whereby the misfolding modifies the activity of the RNA molecules |
| 02/12/2004 | US20040029824 Antisense modulation of glioma-associated oncogen-1 expression |
| 02/12/2004 | US20040029823 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| 02/12/2004 | US20040029792 Isolation nucleic acids; determination, measurement, calibration; genetic engineering |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029274 Antisense modulation of EDG5 expression |
| 02/12/2004 | US20040029273 Endothelial differentiation gene 1 (EDG1); using antisense compounds for modulation of EDG1 expression and for treatment of diseases associated with expression of EDG1 |
| 02/12/2004 | US20040029272 Antisense modulation of perilipin expression |
| 02/12/2004 | US20040029249 Proteases |
| 02/12/2004 | US20040029230 DNA strands useful for the production of parahydroxycinnamic acid and photoactive yellow protein in a suitable host expression system |
| 02/12/2004 | US20040029228 Cytokine receptor |
| 02/12/2004 | US20040029225 Lipoxygenase |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029219 The proteins are antigenic and are useful as vaccine components to raise a protective immune response against Candida |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 02/12/2004 | US20040029174 End selection in directed evolution |
| 02/12/2004 | US20040029160 A triplex comprising a hairpin having polypyrimidine sequence linked to a complementary polypurine; targeting single-stranded oligonucleotides and DNA using the hairpins and triplexes |
| 02/12/2004 | US20040029158 HOP - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 02/12/2004 | US20040029156 Immobilization of biomolecules on substrates by attaching them to adsorbed bridging biomolecules |
| 02/12/2004 | US20040029142 Methods and kits for detecting the presence of a predefined nucleotide at a predefined position in a nucleic acid; used in diagnosis of disorders in a subject |
| 02/12/2004 | US20040029139 System for simultaneous detection of multiple binding events in the same reaction |
| 02/12/2004 | US20040029136 Diagnosing, treating, or preventing disorders associated with aberrant expression of lipid metabolism molecules (LMM) |